CLINICAL OUTCOMES AND COSTS OF SECOND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

被引：0

作者：

Khera, N. ^{[1
]}

Storer, B. E. ^{[1
]}

Chapko, M. K. ^{[2
]}

Lee, S. J. ^{[1
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[2] VA Puget Sound, Seattle, WA USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2011.12.363

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

372

引用

页码：S341 / S342

页数：2

共 50 条

[1] Costs of Second Allogeneic Hematopoietic Cell Transplantation
Khera, Nandita
Storer, Barry
Sandmaier, Brenda M.
Chapko, Michael K.
Lee, Stephanie J.
TRANSPLANTATION, 2013, 96 (01) : 108 - 115
[2] Outcomes of Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children
Schechter, Tal
Avila, Laura
Dupuis, L. Lee
Pollock-BarZiv, Stacey
Gassas, Adam
Finkelstein, Yaron
Armstrong, Christine
Doyle, John J.
BLOOD, 2008, 112 (11) : 1119 - 1119
[3] Costs of allogeneic hematopoietic stem cell transplantation
Svahn, BMBMS
Alvin, OOA
Ringden, OOR
Gardulf, AAG
Remberger, MMR
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 25 - 25
[4] Costs of allogeneic hematopoietic stem cell transplantation
Svahn, Britt-Marie
Alvin, Ole
Ringden, Olle
Gardulf, Ann
Remberger, Mats
TRANSPLANTATION, 2006, 82 (02) : 147 - 153
[5] Outcomes of Second Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia in Our Institution
Okuhiro, Yuki
Tanimura, Kazuki
Hira, Kota
Yamasaki, Kai
Nitani, Chika
Okada, Keiko
Fujisaki, Hiroyuki
Hara, Junichi
PEDIATRIC BLOOD & CANCER, 2019, 66 : S94 - S94
[6] Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia
Yalniz, Fevzi F.
Saliba, Rima M.
Greenbaum, Uri
Ramdial, Jeremy
Popat, Uday
Oran, Betul
Alousi, Amin
Olson, Amanda
Alatrash, Gheath
Marin, David
Rezvani, Katayoun
Hosing, Chitra
Im, Jin
Mehta, Rohtesh
Qazilbash, Muzaffar
Joseph, Jacinth Joy
Rondon, Gabriela
Kanagal-Shamanna, Rashmi
Shpall, Elizabeth
Champlin, Richard
Kebriaei, Partow
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (08): : 689 - 695
[7] Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant
Al-Shaibani, Eshrak
Bautista, Rhida
Lipton, Jeffrey H.
Kim, Dennis D.
Viswabandya, Auro
Kumar, Rajat
Lam, Wilson
Law, Arjun D.
Al-Shaibani, Zeyad
Gerbitz, Armin
Pasic, Ivan
Mattsson, Jonas
Michelis, Fotios, V
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05) : E327 - E334
[8] Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Myeloid Leukemia
Yalniz, Fevzi
Saliba, Rima
Greenbaum, Uri
Ramdial, Jeremy
Alousi, Amin
Joseph, Jacinth
Olson, Amanda
Alatrash, Gheath
Marin, David
Rezvani, Katayoun
Hosing, Chitra
Im, Jin
Shpall, Elizabeth
Mehta, Rohtesh
Qazilbash, Muzaffar
Popat, Uday
Oran, Betul
Champlin, Richard
Kebriaei, Partow
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S202 - S202
[9] Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Huselton, Eric
Slade, Michael
Abboud, Camille
Cashen, Amanda
DiPersio, John F.
Ghobadi, Armin
Pusic, Iskra
Romee, Rizwan
Uy, Geoffrey L.
Vij, Ravi
Westervelt, Peter
Schroeder, Mark A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S278 - S278
[10] Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy
Saullo, Jennifer L.
Li, Yanhong
Messina, Julia A.
Thompson, Jillian
Dalton, Tara
Giri, Vinay K.
Reed, Shelby D.
Miller, Rachel
Horwitz, Mitchell E.
Alexander, Barbara D.
Sung, Anthony D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : 568 - 580

← 1 2 3 4 5 →